Comparitive study between surgical and nonsurgical management in patients with obstructive jaundice due to choledocholithiasis by Gunaseelan, P
COMPARITIVE STUDY BETWEEN SURGICAL AND NONSURGICAL 
MANAGEMENT IN PATIENTS WITH OBSTRUCTIVE JAUNDICE DUE TO   
CHOLEDOCHOLITHIASIS   
 
By  
DR.P.GUNASEELAN., 
Dissertation Submitted to the  
 
TAMILNADU DR MGR MEDICAL UNIVERSITY 
In partial fulfillment 
Of the requirements for the Degree of  
MASTER OF SURGERY  
In  
GENERAL GURGERY 
Under the guidance of  
 
PROF.P. RAGUMANI .,M S ., PROFESSOR 
DEPARTMENT OF GENERAL SURGERY 
MMC & RGGGH 
  
 
 
 
 
 
DEPARTMENT OF GENERAL SURGERY  
MADRAS MEDICAL COLLEGE AND RGGGH 
CHENNAI – 600 003 
 
 
 
 
 
 
 
 
 
 
 
DECLARATION BY THE CANDIDATE  
 
              I hereby declare that this dissertation “COMPARITIVE 
STUDY BETWEEN SURGICAL AND NONSURGICAL 
MANAGEMENT IN PATIENTS WITH OBSTRUCTIVE 
JAUNDICE DUE TO   CHOLEDOCHOLITHIASIS " is a bonafide  
and genuine research work carried out  by me under the guidance of 
PROF.P.RAGUMANI., M S., Professor, Department of General 
Surgery,  MMC & RGGGH , CHENNAI. 
 
 
 
  DATE:     
PLACE:                                                DR P.GUNASEELAN  
                                                      PG IN  GENERAL SURGERY  
                                                                 MMC & RGGGH 
CERTIFICATE BY THE GUIDE 
 
This to certify that the dissertation entitled  
‘‘COMPARITIVE STUDY BETWEEN SURGICAL AND NONSURGICAL 
MANAGEMENT IN PATIENTS WITH OBSTRUCTIVE JAUNDICE DUE 
TO   CHOLEDOCHOLITHIASIS’’ 
is a bonafide 
research work done by Dr. .P.GUNASEELN  in partial 
fulfillment of the requirement for the degree of  
Master of Surgery in General Surgery. 
 
Date :                                                                        PROF P.RAGUMANI .,M S .,  
Place:                                                                      PROFESSOR                            
DEPT. OF GENERAL SURGERY 
                                                                  MMC & RGGGH 
 
ENDORSEMENT BY  
THE HEAD OF THE DEPARTMENT AND  
DEAN 
This to certify that the dissertation entitled  
‘‘COMPARITIVE STUDY BETWEEN SURGICAL AND NONSURGICAL 
MANAGEMENT IN PATIENTS WITH OBSTRUCTIVE JAUNDICE DUE 
TO   CHOLEDOCHOLITHIASIS’’   
is a bonafide research work done by  Dr.P.GUNASEELAN  under the 
guidance of PROF P RAGUMANI., M S., Professor, Department of General 
Surgery , MMC & RGGGH , CHENNAI. 
 
PROF. S. DEIVANAYAGAM                    PROF. V. KANAGASABAI 
HOD, Dept. Of General Surgery                              THE DEAN, 
MMC &RGGGH , Chennai.                                MMC & RGGGH 
Date :                                                  Date : 
Place :                                                 Place : 
ACKNOWLEDGEMENTS 
I express my deep sense of gratitude and indebtedness to my respected 
teacher and guide, PROF P . RAGUMANI ., Professor , Department of 
General Surgery , MMC & RGGGH, whose valuable guidance and constant 
help have gone a long way in the preparation of this dissertation. 
      I acknowledge my sincere and heartfelt thanks with gratitude to PROF. S. 
DEIVANAYAGAM., Professor and Head , Department of General Surgery, 
MMC & RGGGH for his constant help , advise and management .  
       I express my sincere and heartfelt gratitude to my former chiefs PROF A. 
PERIASAMY M S., for his clinical classes and lectures and whose valuable 
guidance and constant help have gone a long way in the preparation of this 
dissertation. 
     I am also thankful to Assitant professors , DR. MADHIVADHANAM., 
DR. N.SELVARAJ, DR. PARIMALA, DR. ABDUL RAHIM , DR. 
KOPERUNDEVI., for their timely suggestions.  
      I express my thanks to the DEAN , Madras Medical College and 
RGGGH, CHENNAI , for allowing me to utilise the resources of the college 
and hospital for this study. 
    I express my thanks to all all of the staff members of Department of 
General Surgery , and all my postgraduate colleagues and friends for their 
help during my study and preparation of this dissertation. 
    I always remember my family , for their everlasting blessings and 
encouragement. 
Lastly , I express my thanks to my patients without them this study would not 
have been possible. 
DATE                                                                               DR P.GUNASEELAN  
PLACE:                                                                  PG IN  GENERAL SURGERY  
                                                                     MMC & RGGGH 
 
 
 
LIST OF ABBREVATIONS USED 
1. CBD           Common bile duct 
 
2. CBDE         Common bile duct exploration 
 
3. DB              Direct Bilirubin 
 
4. DOA            Date of admission 
 
5. DOD            Date of discharge 
 
6. DOS            Date of Surgery  
 
7. ERCP          Endoscopic retrograde cholangiopancreatography 
 
8. GB              Gall bladder 
 
9. IP.No          In patient number 
 
10. IOC          Intra operative cholangiogram 
 11. LFT          Liver function test 
 
12. LRTI        Lower respiratory tract infection 
 
13. MRCP      Magnetic resonance cholangiopancreatography 
 
14. SSI        Surgical site infection 
 
15. TB            Total bilirubin 
 
16. TDS         Trans duodenal sphincterotomy 
 
17. USG         Ultrasonography abdomen 
18.PT             Prothrombin time 
 
 
 
 
ABSTRACT: 
BACKGROUND: 
         Obstructive jaundice is a frequent manifestation of biliary tract disorders.  
Evaluation and management of patients with jaundice is one of the challenging  
problems confronting to the surgeon. CBD stones usually  remain asymptomatic.  
Stones in biliary tree is the most common cause of obstructive jaundice. 10% to 
18% of patients undergoing cholecystectomy for gallstones have CBD stones. 
OBJECTIVE: 
 1.ERCP versus open surgical bile duct clearance. 
2. To compare the post procedural morbidity and mortality 
MATERIALS AND METHODS: 
           50  Patients with obstructive jaundice due to choledocholithiasis in Rajiv 
 Gandhi Government General hospital were studied between June 2011 to 
December   2013 
RESULTS: 
      ERCP was less successful than open surgery in CBD stone clearance . There  
was  increased rate of  post operative  morbidity in patients treated with open  
surgery.  
 
CONCLUSION:  
                Open surgery has got high post procedural morbidity and low failiure 
rate when compared to  ERCP. 
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                                  1.INTRODUCTION 
          cholestatic jaundice is a frequent manifestation of biliary tract disorders.  
Evaluation and management of patients with jaundice is one of the challenging  
problems confronting to the surgeon. 
           Cholelithiasis is a common surgical problem which makes Cholecystectomy  
one of the most frequently performed surgical procedures. CBD stones complicate   
the working and management of cholelithiasis necessitating additional diagnostic  
and therapeutic procedures and adds to morbidity and mortality of gall stone  
disease. 
      Although the stones in the CBD may be silent, the development of symptoms is  
potentially serious; obstructive jaundice, ascending cholangitis, acute pancreatitis  
are all associated with serious morbidity and at times, mortality which need  
immediate attention. 
              Common bile duct stones are present in approximately 5% of the patients  
undergoing elective cholecystectomy and 10% of patients with acute cholecystitis.  
No single blood test or combination of blood tests can predict whether or not a  
CBD stone is present. Intraoperative cholangiography is a gold standard for 
diagnosis , but CBD stones can be diagnosed preoperatively with ultrasound,ERCP  
or MRCP. 
    
       If CBD stones are diagnosed preoperatively, several different treatment  
modalities can be utilized. The factors that determine the optimal approach include  
the patient’s age and general condition. 
      In the era of open cholecystectomy, most CBD stones found at surgery were  
managed surgically with only a minority managed by the alternative,namely,  
endoscopic retrograde cholangiopancreatography with or without endoscopic  
sphincterotomy (ERCP/ES) (Fletcher 1994). Studies suggested that surgical CBD  
stone extraction was the recommended  option. 
 
   
 
 
 
 
                               
 
                         2. REVIEW OF LITERATURE 
HISTORICAL PERSPECTIVE 
           The first open cholecystectomy was performed by Lagenbuch in 1882 .The  
first surgical exploration of the common bile duct was done in 1890 by Ludwig  
Courvoisier, a Swiss surgeon who made an incision in the common bile 
duct and removed a gall stone. 
          Choledocholithiasis is present in approximately in 10% of those who present  
for cholecystectomy. Definitive treatment of these patients include  
cholecystectomy and clearance of the entire ductal system. Courvoisier answered 
this challenge in the era of open biliary surgery in 1890, nearly eight years after  
Langenbuch performed his first cholecystectomy in 1882. 
          One of the first descriptions of common bile duct pathology was the report  
of cholangitis by Jean Martin Charcot, a French physician. In 1877, he published 
the clinical symptoms associated with the passage of common duct stones that we  
now know as Charcot’s Triad- Right upper quadrant pain, fever with chills and  
jaundice . These clinical findings were extended by Telfer Reynolds, a 
hepatologist in Los Angeles, who recognized the presence of hypotension and  
altered mental status related to sepsis in cholangitis. Imaging of the biliary tree  
began with cholecystography by Evarts Graham and Warren Cole in 1924 .  
                
       Transhepaticocholangiography was developed by Carter and Saypol in 1952. 
The introduction of intraoperative cholangiography by Mirrizi in 1934 helped to 
further refine the indications for the CBD exploration. 
          An ironic historic vignette involves one of America’s most prominent 
surgeon – William Stewert Halsted and his travails with the CBD . William 
Halsted died in 1922 following complications from his own two bile duct 
operations. 
         Hans Kehr, a German surgeon, contributed to biliary surgery by his book 
“The Practice of Biliary Tract Surgery in Words and Pictures” and development of 
the T-tube, which is still known as Kehr’s Tube. For surgeons practicing from 
1940 to 1990, open CBD exploration was a commonly performed operation. 
         The development of ERCP in 1968 and endoscopic spincterotomy in 1974 
allowed removal of common duct stones  without a laparotomy. Though initially 
applied to patients felt to be poor surgical candidates, endoscopic transpapillary 
therapy gained increasing popularity over the next 20 years. One hundred years 
later (from the first cholecystectomy) in late 1980s, laparoscopic cholecystectomy 
was introduced, and soon became the standard of care for treatment. This was soon 
followed by the introduction of several minimally invasive techniques that have 
proven successful in treatment of choledocholthiasis in the laparoscopic era of 
biliary tract surgery. 
                                      ANATOMY 
COMMON BILE DUCT(DUCTUS CHOLEDOCHUS) : 
         The common bile duct begins at the union of the cystic and common hepatic 
ducts and ends at the papilla of  Vater in the second part of the duodenum. Length 
of CBD varies  from 5 cm to 15 cm. The  diameter of CBD varies from  4mm to 6 
mm. 
         The common bile duct (CBD) can be divided into four portions or segments 
         1.Supraduodenal - average length of 2 cm 
         2. Retroduodenal – average length of 1.5 cm 
         3. Pancreatic – average length of 3 cm 
         4. Intraduodenal – average length of 1.1 cm. 
 
                  
 Supraduodenal Portion 
                 This part lies between the two leaves of the hepatoduodenal ligament, in 
front of the foramen of Winslow to the right of the hepatic artery, and anterior to 
the portal vein. One or more of the following may cross the supraduodenal portion 
anteriorly: right gastric, right hepatic, supraduodenal or even gastroduodenal 
artery. The relation of the right hepatic artery may lie to the right, left, anterior or 
posterior to the common bile duct. 
Retroduodenal Portion 
               This part lies between the superior margin of the first part of the 
duodenum and the superior margin of the head of pancreas. The gastroduodenal 
artery is to the left and the posterosuperior pancreaticoduodenal artery crosses first 
anterior to the bile ducts and then posterior to the duct just before it enters the 
duodenum. 
Pancreatic Portion 
                   The pancreatic portion is covered by a pancreatic extension (tongue) in 
various proportions from completely covered (30%) to partially covered (44%) to 
uncovered (16.5%). The above description predicts the ease with which stone may 
be palpated after mobilization of Second part of the duodenum with Kocher’s  
Maneuver. 
Intramural:        
            This part passes obliquely through the duodenal wall together with main 
pancreatic duct. Within the wall, the length average 15 mm10 as it enters the 
wall,the common bile duct decreases in diameter from 5.7 to 3.3 mm11. The two 
ducts lie side by side with a common adventitia for several millimeters. The 
dividing septum becomes reduced to a mucosal membrane just before the 
confluence of the ducts. 
          The duodenal papilla (of Vater) lies at the end of the Intramural portion of 
the CBD. It is on the posteromedial wall of the second part of the duodenum. The 
distance of the papilla from the Pylorus is highly variable from 8 to 12 cm. 
              There is a complex of four sphincter composed of circular or spiral 
smooth muscle fibres surrounding the intramural portion of the CBD and 
pancreatic ducts. The sphincter is developmentally and functionally distinct from 
the duodenal musculature. The entire complex is called sphincter of oddi                                    
 
           Incision of 5 mm steps while testing with a suitable dilator will help limit 
the incision of papillotomy to the shortest length necessary. On mucosal surface, 
the duodenal papilla of vater is found where a longitudinal mucosal fold meets a 
transverse fold to form a T.The Ampulla is the common pancreaticobiliary channel 
below the junction of the ducts within the papilla. 
                      It is classed into 3 types based on Michel’s description . 
Type 1. The pancreatic duct opens into the CBD, but at a variable distance from 
the orifice of duodenal papilla (85%). 
Type 2. The pancreatic and CBD open separately on the duodenal papilla (5%).                   
Type 3. The pancreatic and CBD open into the duodenum at separate points (9%).                             
 Diameter of the CBD 
The diameter measured varies with procedure performed to measure it . (Surgical 
inspection, cholangiogram, USG). 
            A CBD has been considered to be definitely enlarged, when: 
> 8mm Drouin, 1964 
> 10 mm Roux et al, 1959 
> 12 mm LeQuesne et al, 1959 
> 15 mm Longmire, 1963. 
            Hence, there is no consensus. But there is agreement on the fact that a CBD 
less than 5.7 mm is certainly normal and one over 10.8 mm indicates obstruction. 
Ducts between these values must be considered equivocal. At 10.2 mm, the 
probability of pathology in the duct is 50%. 
Arterial Supply of the CBD 
The upper portion is supplied by the cystic artery. The lower portion is  supplied by 
a branch from posteriosuperior pancreaticoduodenal and retroduodenal artery. 
There is a subepithelial, intramural and an epicholedocal plexus of vessels around 
the CBD. These provide collateral circulation between the cystic artery above and 
the superior pancreaticoduodenal artery below. Gastroduodenal  branches to CBD 
runs on the side of  CBD at 3 ‘o’ clock and 9 ‘o’ clock position. 
                  
Venous Drainage of the CBD 
The upper portion drains via the cystic vein into the hepatic vein. An 
Epicholedocal venous plexus on the CBD helps the surgeon identify the CBD. 
However stripping of the CBD is not permissible.  
 
Lymphatic Drainage 
      The CBD drains into pericholedocal nodes which in turn drain into preaortic 
nodes around the celiac and superior mesentric artery. 
 
Nerve Supply 
          Both sympathetic and parasympathetic (vagal) fibres derived from the  celiac 
plexus reach the biliary tract as they follow the hepatic artery and its  branches. The 
action of sympathetic nerves is vasomotor but that of parasympathetic is not 
known. Complete vagotomy does not impair bile output but it appears to result in a 
permanently enlarged gall bladder . 
CHOLEDOCHOLITHIASIS 
       Common bile duct stones are classified both by their point of origin as well as 
the time at which they are discovered relative to cholecystectomy. 
A. Point of Origin: 
1. Secondary Bile Duct Stones:  
               These form in the gall bladder and pass down through the cystic 
duct into the CBD. Most CBD stones are of this type.Therefore, patients 
with CBD stones usually have gallstones. Even in cases where the gall 
bladder does not contain stone, chronic inflammatory changes in its wall and 
sludge in its Lumen indicate the presence of stones previously. 
 2.Primary Bile Duct Stone:  
             To prove, that a stone originated in the CBD, is difficult except in cases of 
gall bladder agenesis. Saharia et al proposed the following criteria for primary 
CBD stones. 
       Patient should meet all the criteria, viz : 
� Previous cholecystectomy with/without CBD Exploration. 
� At least two years of symptom free interval after previous biliary surgery. 
� Soft friable brown stones/ sludge in CBD. 
� Absence of a long cystic duct or biliary stricture due to previous surgery. 
           Primary CBD stones are associated with the biliary stasis and infection. 
They are usually brown pigment type, which are soft and crumble easily when 
manipulated. The causes of the biliary stasis, which lead to their development, 
include biliary stricture, papillary stenosis or sphincter of oddi dysfunction.The 
incidence of primary CBD stone varies from 4% to 56% in different studies. The 
incidence of secondary CBD stone is age sensitive and varies from 
11% to 18% as older patient have had gallstones for a longer period of time. 
 
 
 
B. In Relation to Cholecystectomy: 
1. Retained:  
           CBD stones are defined as retained if they are discovered within 2 years of     
cholecystectomy. The stones have characteristics of secondary stones. 
2.Recurrent:  
           CBD stones are defined as recurrent if they are detected more than 2 years 
following cholecystectomy. 
NATURAL HISTORY OF CBD STONES 
             CBD stones may remain asymptomatic for long periods. Clinically silent 
passage into the duodenum is known to occur in CBD stones, when they cause 
symptoms, present with margin complications like cholangits or pancreatitis. The 
morbidity of CBD stone is mainly due to biliary obstruction. CBD stones usually  
come to rest at the lower end of the CBD, at the ampulla of vater. CBD obstruction 
causes the proximal duct to dilate and increases the pressure inside the duct. 
Normal intraductal pressure is 10 – 15 cm of H2O. This rises to 25-40 cm of 
H2O with complete obstruction. When the pressure increases to >15cm of H2O, 
bile flow decreases and flow stops at 30cm of H2O pressure. Therefore, during 
contact dissolution of retained CBD stone the pressure inside the duct should be 
monitored and maintained at below 15 cm of H2O. The degree and rate of onset of 
obstruction and the amount of bacterial contamination of bile are the major factors 
that determine the symptoms. Acute obstruction usually causes biliary colic and 
Jaundice. Gradually developing obstruction may present with Jaundice alone. If 
bacteria proliferate cholangitis may result. In patients who have had recurrent 
bouts of cholangitis, the duct may become fibrotic and unable to dilate. If the 
obstruction is low grade and intermittent, the duct may not be dilated. If 
incomplete obstruction persists for a long time before a diagnosis is made 
secondary biliary cirrhosis with portal hypertension may develop which ultimately 
may progress to hepatic failure. To summarize the clinical cause may be 
complicated by acute gall stone pancreatitis, cholangitis or rarely hepatic abscess.  
The average time for choledocholithiasis to lead to biliary cirrhosis is 5 yrs 
depending on the extent of obstruction. 
COMPOSITION OF CBD STONES 
1.Primary Stones.  
                They usually are of the brown pigment variety. These tend to be lower in 
cholesterol content and higher in bilirubin content secondary to biliary stasis and 
bacterial infection.  
2. Secondary Stones.  
            These are cholesterol stones in 75% and black pigment stones in 25% of 
patients. Cholesterol stones are formed in the presence of cholesterol saturation, 
biliary stasis, and nucleating factors. The formation of  black pigment stones is 
associated with hemolytic   disorders, cirrhosis, ileal resections, prolonged fasting 
and   total parenteral nutrition. 
INDICATORS OF CHOLEDOCHOLITHIASIS. 
INDICATOR SENSITIVITY SPECIFICITY 
   
Cholangitis 11% 99% 
Choledocholithiaisis  on USG 38% 100% 
Preoperative jaundice 36% 97% 
Dilated CBD on USG 42% 96% 
Jaundice 39% 92% 
Elevated bilirubin 69% 88% 
Eleated alkaline phosphatase 57% 86% 
Pancreatitis 10% 95% 
Acute cholecystitis 50% 76% 
Elevated amylase 11% 95% 
 
DIAGNOSIS AND EVALUATION 
In the last decade, many refinements and advancements have been made in 
radiology; endoscopy and clinical laboratory testing that have improved the 
diagnosis and evaluation of patients with choledocholilithiasis and cholangitis. In 
some respect, the available tests are so numerous that care must be exercised to 
avoid over utilizing them. A careful old-fashioned but time honoured history and 
physical examination will guide the clinician in the proper direction in most cases. 
        A patient with symptomatic CBD stones may have the following: 
CLINICAL FEATURES 
1) Pain. 
                Abdominal pain commonly is intermittent but may be constant also. The 
pain is usually present as a deep visceral, mid epigastric pain and is often 
associated with nausea and or vomiting. Presence of fever points to cholangitis   
whereas in 20% of patients, back pain may be the prominent symptom and raises  
the possibility of associated pancreatitis. 
 
2) Obstructive Jaundice. 
                 A  small stone passes into the bile duct and impacts in the ampulla, 
causing pain and jaundice. The severity of jaundice depends on the duration of 
obstruction, but as the stone passes on, the jaundice resolves spontaneously. More 
commonly, there is a larger stone or stones within a dilated 
bile duct. Sometimes, the number of stones in the duct leads to significant 
impairment of bile flow. At other times, a stone moves up and down within the 
duct and acts as a ‘ball Valve’, causing pain and jaundice when it impacts, but 
allowing the symptoms to resolve spontaneously as the stone floats up. The site of 
impaction is usually immediately above the ampulla, but it may be above a fibrotic 
narrowing in the bile duct, caused by the stone themselves. Complete 
impaction of a stone causes severe, progressive jaundice. Stones in the bile duct 
cause pain. However, from pain alone it is not easy to diagnose obstructive 
jaundice due to stone from that due to malignant disease. 
 
3) Ascending Cholangitis 
                 The classic presentation of patient with cholangitis was described as 
fever, jaundice and abdominal pain by Charcot .However, 1/3 to 1/2 of patients 
will not have the complete triad. Reynolds and Dargan added the presenting 
symptom of shock and mental obtundation to the triad, to describe a group of 
patients with severe forms of the disease. Cholangitis is always associated with 
some degree of obstruction within the bile duct; stones in the duct are the cause in 
80% of cases. Bile duct obstruction by stone release cytokine, which activate 
bacterial biofilm on these stones. There is a synergy of aerobic (E.coli, S.fecalis) 
and anerobic (B.fragilis, clostridium perfringens). 
4) Acute Pancreatitis 
                  Impaction of small stone at the ampulla and occlusion of pancreatic 
duct is a cause of acute pancreatitis. An early ultrasonographic examination of the 
biliary tract is therefore essential in every patient who is admitted with acute 
pancreatitis, particularly, if there is any change in the liver function tests. A few 
have evidence of a stone in the bile duct and an immediate endoscopic 
sphicterotomy and extraction of the stone may abort the episode of pancreatitis. 
The following signs may be present: 
        Patient may be icteric and toxic, with high fever and chills or may appear to 
be perfectly healthy. A palpable gall bladder is unusual in patients with obstructive 
jaundice from common duct stone because, the obstruction is transient and partial, 
and scarring of the gall bladder renders it inelastic and non-distensible 
(Courvoisier’s law). Tenderness may be present in the right upper quadrant but is  
not as marked as in acute cholecystitis. Tender hepatic enlargement may occur. 
BIOCHEMICAL PARAMETERS: 
1. Serum Bilirubin: 
              In the routine clinical laboratory, total and direct reacting bilirubin are 
determined. Conjugated (direct) can be accurately assessed by high performance 
liquid chromatography; this has been found highly specific for cholestatic liver 
disease. A rise in serum bilirubin often appears within 24 hr after the onset of 
symptoms. The absolute level usually remains under 10 mg/dl and most are in the 
range of 2-4 mg/dl. The direct (conjugated) fraction exceeds the indirect, but the 
later becomes elevated in most cases. Bilirubin levels do not ordinarily reach the 
high values seen in malignant tumour because the obstruction is usually transient 
and incomplete. In fact, fluctuating jaundice is so characteristic of 
choledocholithiasis that it fairly reliably differentiates between benign and 
malignant obstruction. After long standing obstruction bilirubin becomes 
covalently bound to serum albumin C, the so called delta bilirubin . This fraction 
disappears from serum with half life of albumin (20 days); this phenomenon 
accounts for the slow resolution of jaundice after relief of standing obstruction in 
spite of otherwise normal liver function.  
2.Serum Alkaline Phosphatase 
                 The serum alkaline phosphatase level usually rises after biliary 
obstruction and may be the only chemical abnormality in patients without jaundice. 
The elevation of alkaline phosphatase in hepatobiliary disease is due to increased 
synthesis perhaps, stimulated by bile acids39. This explains why in patients with 
acute biliary obstruction, the elevation of alkaline phosphatase often lags behind 
the onset of symptom and even jaundice. When obstruction is relieved, the alkaline 
phosphatase and bilirubin levels return to normal within 1 – 2 weeks with the 
exception that the former may remain elevated longer if the obstruction was  
prolonged.  
3. Gamma-glutamyl transpeptidase (GGT) 
                 GGT increases markedly (upto 40 fold) in mechanical bile 
ductobstruction. It has been proposed that the ALT/GGT ratio was better able to 
differentiate between obstructive jaundice and hepatitis than alkaline phosphatase 
or any of the enzymes taken alone. 
 
RADIOLOGICAL IMAGING 
Abdominal Sonography 
              This is the first imaging investigation of choice to be used as it needs no 
special preparation, involves no ionizing radiation, simple to perform, provides 
accurate anatomic information, is portable and is non-invasive. It has been the 
single most valuable screening tests in the jaundiced patient in recent years . The 
presence of associated gall bladder stone can be confirmed in >98% and dilation of 
the intrahepatic biliary system can be identified.Unfortunately, its sensitivity for 
the detection of the CBD stone is only 15% to 30%. This is because the distal end 
of CBD is frequently obscured by duodenal or colonic gas. The presence of a stone 
can be inferred by the presence of dilated CBD, This has a sensitivity of 75%, the 
normal CBD measures 6 mm on ultrasound, and USG can often determine the 
cause of obstruction. The demonstration of stones in the CBD depends upon their 
size and position. Large stones(>5 mm) usually can be visualised. Smaller stones 
may not cast an acoustic shadow and are more difficult to detect because, they 
lodge further down the duct, where duodenal gas may degrade the image. 
Ultrasound has proved to be thoroughly reliable for detection of biliary dilation but 
it can be misleading in rare cases in which a partial obstruction is examined early, 
after the onset of obstruction before the dilation has developed . 
 
Endoscopic Ultrasound 
                    Endoscopic ultrasound is a semi-invasive test that  can be performed 
with very low rates of complications(< 0.1%) . The negative predictive value of 
endoscopic ultrasound is more than 97%. Therefore, when endoscopic ultrasound 
is negative for CBD stones, ERCP or intraoperative cholangiography can be 
avoided. 
Magnetic Resonance Cholangiopancreatography (MRCP) 
                 MRCP has recently been developed as another non-invasive means of 
imaging the biliary tract. MRCP can diagnose CBD stones with sensitivity of  
90%, a specificity of 100% and an overall diagnostic accuracy of 97%. The main 
advantage is that it allows for direct imaging of biliary tract without the need for 
contrast or an invasive procedure. The disadvantages include high cost, lack of 
availability and lack of therapeutic capacity. MRCP has been used to screen 
patients at low and moderate risk of having CBD stones prior to ERCP. A normal 
MRCP avoids the need for ERCP. 
Intraoperative Cholangiography (IOC) 
            IOC can be successfully accomplished in more than 95% of the cases. It 
should be carefully evaluated for filling defects within the ducts, presence of 
contrast in the duodenum and the intrahepatic biliary anatomy. Debate continues 
over the need to perform routine intraoperative cholangiography. Advocates of its  
routine use argue that asymptomatic CBD stones can be identified and biliary 
injury can be prevented by performing it routinely. Critics suggest that incidence of 
retained stones is no greater when cholangiography is performed selectively, based 
on clinical and laboratory criteria. The indicator for performing cholangiography 
during cholecystectomy include 
• A dilated CBD 
• A wide cystic duct 
• Palpable CBD stones 
• Elevated LFT 
• History of cholangitis, pancreatitis 
                      If these criteria are strictly followed, approximately 30% of the 
patients will require IOC at the time of cholecystectomy. IOC can identify the size, 
number and location of CBD stones in addition to defining biliary anatomy. This 
information is critical in choosing the most appropriate treatment for CBD stones.                
PREOPERATIVE PREPARATION OF THE PATIENT WITH 
OBSTRUCTIVE JAUNDICE. 
              Adequate timing of the surgical intervention and preparation of the patient 
for surgery are essential in management of patients with obstructive lesions of the 
biliary tract. Undue delays exceeding 3-4 weeks increase both morbidity and 
mortality rates following surgical intervention. Adequate preparation entails the 
correction of metabolic abnormalities, improvement of the general condition o the 
patient  and  measures  to minimize the incidence of complications associated with 
prolonged or severe cholestasis  include: 
1. Infections: cholangitis, septicemia, wound infection 
2. Disorders of the clotting mechanism 
3. Renal failure 
4. Liver failure 
5. Fluid and electrolyte abnormalities. 
             No evidence exists to support that wound healing is impaired in the 
presence of jaundice. Wound healing problems are largely confined to patients 
with malignant obstruction and are result of the underlying disease and its  
association with poor nutritional state.Oral diet is the safest,as enteral nutrition is 
considered essential for the maintenance of the mucosal integrity of the gut against 
bacterial translocation. Hypokalemia is frequently present and should be managed. 
Intravenous isotonic saline  should  not be administered. 
PREVENTION OF INFECTIVE COMPLICATIONS: 
                Infections of the biliary tract is much more commonly present in ductal 
calculous disease. In the absence of stenting, the majority of infections associated 
with biliary tract disorders are aerobic in origin and most commonly due to Gram 
negative bacilli. The use of prophylactic antibiotic therapy with a cephalosporin or 
aminoglycoside or piperacillin has shown to reduce the incidence of postoperative 
wound infections, cholangitis and  septicemia. Bacterial proliferation in the bile 
following exploration of the  CBD and insertion of a T-tube is extremely common 
and may become a source of infection and lead to the formation of calcium 
bilirubinate stones as a result of the deconjugation of the bilirubin-glucoronide by 
glucorinidase producing bacteria, particularly E.coli. Thus, a closed system of 
drainage should always be used and a bile culture performed a few days before the 
removal of the T- tube. A course of the appropriate antibiotic should be 
administered if the culture is positive. 
 
CORRECTION OF DISORDERS OF COAGULATION 
              The most common disorder of coagulation encountered in patients with 
large bile duct obstruction is a prolonged prothrombin time due to the deficiency of 
Vitamin-K dependent factors. The intramuscular injection of Phytomenadione (10-
20mg) will reverse the multifactorial clotting factors deficiency within 1-3 days. In 
severe hepatic disease, if the prothrombin time remains prolonged despite the 
above treatment, administration of fresh frozen plasma is necessary in  the peri-
operative period. 
 
PREVENTION OF RENAL FAILURE 
           The association between post-operative renal failure and severe conjugated 
hyperbilirubinemia is well known but the underlying mechanism of the renal 
impairment is inadequately understood, although a reduced glomerular 
filtration is usually present. Irrespective of the exact cause of the renal damage, 
there is good evidence that adequate hydration and pre-operative induction of a 
natriuresis/diuresis reduces the incidence of renal failure after surgical intervention 
in jaundiced patients. It is current routine practice to administer intravenous fluids 
(5% dextrose saline) for 12-24 hrs before surgery. This is followed by an osmotic 
diuretic (mannitol) or a loop diuretic (frusemide) administered intravenously at the 
time of induction of anaesthesia. All patients undergoing surgery should be 
catheterized and urine output measured hourly. Further administration of diuretics 
(mannitol or frusemide) is indicated if the urine output falls consistently below 40 
ml/h(despite adequate hydration and normovolemia) during surgery and 
subsequently thereafter. 
MANAGEMENT OF CBD STONES 
The management of choledocholithiasis with or without cholangitis depends upon 
many variables which include: 
1) Patients general and medical condition 
2) Detection of stones in relation to cholecystectomy – prior, during or after 
cholecystectomy. 
3) Experience of the surgeon 
4) Availability and skill of endoscopists, interventional radiologists. 
SURGICAL MANAGEMENT: 
Open Surgical Management 
               While open cholecystectomy alone may be performed with little 
morbidity, and a mortality of less than 0.5%, the addition of an exploration of bile 
duct increases the morbidity and mortality by 3 to 7 times. This may  be due to the 
fact that the procedure is more often necessary in patients of advanced age and 
associated medical illness. In addition, the longer duration of the procedure and the 
presence of jaundice, cholangitis or pancreatitis in patients with CBD stones 
influence morbidity and mortality. 
Indication for open CBD exploration 
1) Palpable stones in the CBD. 
2) Jaundice with cholangitis 
3) A stone visualized at intraoperative cholangiography 
4) USG evidence of CBD stones. 
5) Patients with failed endoscopic or laparoscopic CBD stone removal 
attempt. 
6) Patients in whom an open cholecystectomy is performed for different reasons 
such as suspicion of cancer, presence of a biliary enteric fistula, Mirrizi’s 
syndrome, should have palpation of the CBD and operative cholangiogram 
performed. If common bile duct stones are visualized, open CBD exploration is 
mandatory. Palpation of the CBD is often underestimated but is the most reliable 
indicator for choledochotomy, having an accuracy of 98% if a stone is judged 
palpable. 
          Obstructive jaundice with fever and chills is indicator of either cholangitis or 
acute cholecystitis. If patients with acute cholecystitis are excluded, this triad will 
be associated with choledocholithiasis in approximately 97%0f the patients. For 
the non jaundiced patient, per op cholangiography is with palpation of stones  the 
most reliable determinant of the presence of CBD stones should be performed 
routinely at open cholecystectomy. 
APPROACH TO THE CBD 
1. Supraduodenal : 
               The common bile duct is exposed above the dudoneum and it is helpful to 
mobilize the second part of the duodenum (Kocher’s maneuver). The 
choledochostomy is longitudinal so as not to compromise the blood supply to the 
duct. The site of the choledochostomy is close to the duodenum to allow 
choledochoduodenostomy if required and to leave the greater length of bile duct 
above the choledochostomy should it be necessary to repair a postoperative bile 
duct stricture. The choledochostomy is performed on the anterolateral surface of 
the CBD in between two stay suture for a length of 2 cm subsequent to a needle 
choledochostomy which confirm the anatomical entity as the CBD. The sample 
bile is sent for culture and sensitivity. The common hepatic duct, right hepatic duct 
and left hepatic duct are explored using Desjardin’s forceps and calculi removed. If 
duct contains small stones or sludge, irrigation can be done using normal saline. At 
the end of the procedure, a Kehr’s T tube of 14Fr is inserted into  CBD. The tube 
should preferably be of latex so as to form a well organized tract from the CBD to 
the outside. It should be brought out through the lower end of incision over CBD, 
the short limb trimmed to 1 cm, the long limb brought out through a stab incision 
in the flank and CBD closed securely over T tube with interrupted PDS sutures. 
Advantages of T Tube Drainage 
1) Decompression of the duct, in case of residual ductal obstruction. 
2) Access for ductal imaging in the postoperative period. 
3) Access for removal of residual common duct stones, should they be left after 
common bile duct exploration. 
         Postoperatively, the T – tube is allowed to drain freely into a sterile closed 
drainage bag. A T – tube cholangiogram is obtained on the ninth or tenth day after 
surgery, and if the duct is clear, the T – tube is clamped. Provided the patient 
does not develop any pain or discomfort, the tube can be removed after 24 hours  of 
clamping it. 
           The only reliable method of confirming complete clearance of CBD is post 
exploratory T – tube cholangiography or choledochoscopy. Pitfalls of open CBD 
exploration include imaging the bile ducts, creating a false passage into the 
duodenum when probing the CBD, sepsis, failing to remove all of the biliary 
calculi. 
2 Transduodenal 
              This is carried out as a part of biliary enteric Drainage procedure or when 
CBD stone are present with CBD diameter < 4 mm when supraduodenal 
exploration of CBD may have future risk of biliary stricture formation. It is further 
detailed under Biliary enteric drainage procedures. 
3 Transcystic 
                  CBD may be explored in a dilated cystic duct and avoids the need for T 
– tube drainage. 
Billiary Enteric Drainage Procedure 
                  Surgical biliary enteric drainage procedure must be considered in 
situations of: 
1) Multiple stones 
2) Incomplete removal of stones 
3) Impacted  distal bile duct stones. 
4) Markedly dilated CBD. 
5) Distal bile duct obstruction from tumour or stricture. 
6) Re-occurrence after previous bile duct exploration. 
The methods of surgical drainage include: 
Transduodenal Sphincterotomy (TDS) 
It is employed when the common duct is less than 1.5cm in diameter in a 
young,low risk patient with a solitary impacted ampullary stone. However in 
elderly and high-risk patient with dilated ducts, choledochoduodenostomy is the 
procedure of choice. The duodenum is kocherised completely and the ampulla is  
located by passing a biliary Fogarty catheter through the CBD into the duodenum. 
A longitudinal duodenotomy is made over the ampulla. The duodenal wall at 11O’ 
clock is incised from the lip of the ampulla to a distance of 3 cm or the first 
transverse fold superior to the papilla. The duodenal mucosa and bile duct mucosa 
are approximated using fine absorbable sutures. The last suture must be placed at 
the apex to avoid duodenal leak. This procedure converts the ampulla into a wide 
stoma and hence incidence of retained stone is very less. The duodenotomy is  
closed transversely to prevent duodenal stenosis. 
Complications 
• Acute pancreatitis. 
• Restenosis of papille. 
• Leak from duodenotomy. 
Choledochoduodenostomy 
           A dilated duct is the sine quo non for this procedure. It should not be 
performed with ducts less than 1.4cm in diameter and a duct narrower than 1.2 cm 
is an absolute contraindication. The FUNNEL SYNDROME in which a distal bile 
duct stenosis is one of the most classic indication. Stomal patency is felt to be the 
most important factor for preventing both cholangitis and sump syndrome. Stoma 
of at least 14 mm, along with placing the anastomosis near the duodenum is 
important.This procedure is preferred because : 
• The anastomosis between distal CBD and the adjacent duodenum is easily made. 
• Danger of pancreatitis is absent. 
• Long term results are good. 
        The choledochotomy is extended upto the duodenum for 2.5 cms. The 
duodenum is opened longitudinally for 1.5 cm along its superior border. A single 
layer absorbable interrupted suture in a side to side fashion are used to 
approximate CBD to duodenum. The knots shall be positioned outside, 2 mm 
apart. The anastomosis is started posteriorly - lower end of CBD opening to 
posterior lip of duodenotomy. 
 
Complications 
• Bile leak 
• Stricture at anastomiosis leading to cholangitis. 
• Sump Syndrome- It is caused by food and debris accumulating between the 
stones and the papilla of vater. This leads to contamination of the large and small 
bile ducts with resulting recurrent cholangitis and even secondary biliary cirrhosis. 
 
                    
        
                       
 
Choledochojejunostomy 
             It is an alternative to choledochoduodenostomy, can be done with either a 
loop or Roux – en Y configuration of Jejunum. The Roux en Y usually is brought 
retro colic using a 60 cm afferent limb to protect against intestinal reflux and 
secondary cholangitis. This procedure is used as an alternative to 
choledochoduodenostomy when the feasibility of creating a tension free 
anastomosis is low.         
                    
 
 
                    
                             
                                     Transduodenal spincterotomy 
                       
                                    Endoscopic spincterotomy 
 
ENDOSCOPIC MANAGEMENT OF CBD STONES 
              In 1968 ERCP was introduced as a diagnostic tool to aid in the 
management of biliary and pancreatic disease48. Five years later, with 
development of endoscopic sphinctecotomy, ERCP was transformed into a 
therapeutic modality. 
Indications 
1) Acute cholangitis irrespective of gall bladder status. 
2) Acute gall stone pancreatitis irrespective of gall bladder status. 
3) Obstructive jaundice. 
4) Post – cholecystectomy, stone(s) shown on intraoperative cholangiogram. 
5) Post – cholecystectomy, retained stone(s), early presentation. 
6) Post – cholecystectomy, late presentation. 
7) Gall bladder in situ, variable risk factor for surgery, possible need for 
subsequent cholecystectomy. 
Shortcomings Of The Endoscopic Approach 
            CBD is inadequately cleared of stones due to 
a) Inability to cannulate the papilla. 
� Duodenal stenosis 
� Roux – en – Y reconstruction 
� Billroth II Gastrectomy 
� Periampullary diverticulum 
b) Inability to extract stone after adequate sphincterotomy due to: 
� Narrow lower bile duct segment 
� Stone > 15 mm in size 
� Intrahepatic stones 
� Stone proximal to a stricture 
� Very large number of stones 
� Stone consistency – hard 
� Stone shape – square 
Technique of Endoscopic Management 
          ERCP stone extraction is successful 80% - 90% of time using the technique 
of sphincterotomy and balloon catheter or Dormia basket stone retrieval.The 
addition of mechanical, electrohydraulic, laser or intracorporeal 
shockwave Lithotripsy for large stones increases the success rate over 95%. The 
procedure is discussed under two headings below: 
A. Access to the stone after selective bile duct cannulation 
1) Endoscopic Sphincterotomy (ES) 
                  Entails division of the papilla and sphincter muscles to widen distal end 
of CBD with an sphincterotome. The incision is vertical and in a cephalad 
direction from the papillary orifice for a length of 10 to 15 mm but not beyond the 
first transverse fold of duodenal mucosa cephalad to orifice in order to prevent 
perforation and hemorrhage. The size of incision depends upon local anatomy, 
degree of CBD dilation and size of stone to be removed. 
2) Balloon sphincteroplasty.  
                    This is a sphincter preserving alternative to sphicterotomy that uses a 
high pressure hydrostatic balloon of 6 to 8 mm diameter to dilate the papilla. One 
drawback is the limited size of the papillary opening created as compared with 
sphincterotomy.Sphincteroplasty has been associated with a pancreatitis rate of 19 
times greater than the rate associated with sphicterotomy. 
B Stone Retrieval. Most stones are retrieved using: 
1) Fogarty Balloon: It is used for removal of small stones and gravel,intrahepatic 
stones. 
2) Dormia Basket: Stone > 1 cm, where better traction is needed. 
           Three situations that may lead to difficult extraction of stones include – 
Stones > 1.5 cm, location proximal to a stricture, multiple impacted stones. In such 
situation additional retrieval techniques may have to be used. 
1) Mechanical Lithotripsy. This is the most common and simplest means of 
fragmenting large bile duct stone or when a significant discrepancy between the 
stone size and the diameter of the exit passage exists. A large strong Dormia basket 
is used to trap the stone. The stone is then crushed 
against a metal sheath by applying tension to the wires by the use of a crank 
handle. Success ranges from 90% for stones less than 1 cm to 68% for stones 
greater than 2.8 cm52. Impaction of the stone in the bile duct was found to be the 
only significant factor that predicted failure of Mechanical Lithotripsy. 
2) Intraductal Shockwave Lithotripsy.  
                       It is used when Mechanical Lithotripsy fails. It is performed using a 
cholangioscope that is inserted into the bile duct through the instrument channel of 
the duodenoscope – based on a ‘Mother – baby scope’ system. A flexible 
Lithotripsy probe then is passed into the bile duct through the working channel of 
the cholangioscope. Shock waves are generated at the tip of the Lithotripsy probe 
using electrical (Electrohydraulic Lithotripsy) or light energy (Laser 
lithotripsy).53Impulses are fired on the surface of the stones under cholangioscopic 
guidance until the needed fragmentation is achieved. The  main risk of intraductal 
shock wave therapy is bile duct injury resulting from a misguided shock wave. The 
avoidance of this complications makes cholangiascopic guidance necessary. 
3) Endoprosthesis Placement. 
                          In a few situations where stone extraction is 
incomplete or impossible because of stone size, local anatomy, bleeding or  
technical difficulty leading to incomplete ES, a nasobiliary tube or endoprosthesis 
is inserted to provide biliary decompression and prevent 
stone impaction in the distal CBD. This serves as a temporizing therapy allowing 
for improvement in the patient’s clinical condition until complete stone clearance 
is achieved either via additional endoscopic maneuvers or 
surgery. 
Complications of ERCP 
1) Pancreatitis: It is the most common complication. The definition for ERCP 
induced pancreatitis is: 
• New or worsened abdominal pain. 
• Serum amylase – 2 or more times the upper limit of normal         24 hrs after the 
procedure. 
• Requirement of at least 2 days of hospitalization. 
Risk factors for ERCP pancreatitis include 
1) Non-dilated biliary ducts, normal bilurubin, young age, female gender, 
suspected sphincter of Oddi dysfunction. 
2) Perforation of the duodenum. 
3) Bleeding. 
4) Cholecystitis 
5) Cholangitis. 
 
 
INTERVENTIONAL RADIOLOGY MANAGEMENT OF CBD STONES 
         Radiology of the biliary tract owes its beginning to contribution from surgery 
with the original description of transhepatic gall bladder puncture in 
921,cholecystography in 1923 and post surgical cholangiography in 1924 . 
Access to the Biliary Tract : 
1) Post operative sinus track 
• T – tube track 
• Cholecystotomy tube track 
2) Percutaneously via transhepatic route. 
T- Tube track access: 
           Instrumentation of a T – tube tract is an easy technical procedure and has 
implication for surgical T – tube placement. Precautions to be taken while inserting 
T – tube include : 
� The caliber of T – tube should be at least 14 fr. 
� The T tube should exit through a stab wound in the right flank in the 
anterior axilliary line. Anterior T – tube tracks should not be made because 
instrumentation is difficult and the operator hands come into field of radiation. 
� Latex T – tube should be used as silicon T – tube cause inadequate inflammatory 
reaction and hence poor sinus track formation. 
� At least a total of 5 weeks should elapse for fibrous tract formation for stone 
extraction Obese, immunosuppressed, T –tube <14 Fr may require more than 5 
weeks interval. 
Transhepatic Route. 
              This approach is used as a last resort when a postoperative drainage tract 
is not available, when surgical or endoscopic stone removal is contraindicated or 
not possible. This is an adaptation of percutaneous transhepatic cholangiography . 
 
 
Cholecystostomy Tract.  
                5 week waiting period after surgical cholecystostomy is needed before 
instrumentation. The CBD is entered through cystic duct. If deliberate 
cholecystostomy is performed, in the high risk patient with CBD stones,then the 
fundus can be sutured to the peritoneum of anterolateral abdominal wall.By this 
instrumentation can be done within 1 week. 
Technique of CBD stone extraction:  
                       Done under conscious sedation. The T-tube is removed and a 
steerable catheter is maneuvered along side the stone. The basket is opened and 
stone ensnared through the T-tube track. This is done under fluoroscopic guidance. 
A 6-7mm stone can be removed through a 14 fr T-tube.Larger stones need to be 
fragmented using mechanical or laser lithotripsy. 
 
Results:  
             The success rate of radiolological percutaneous stone extraction therapy 
through T-tube using basket is 88 to 97%56.The reasons for failure were: 
1) Intrahepatic stones(50% of all cases) 
2) Impacted distal CBD stones. 
3) Inability to cathterise the tract due to a small T-tube tract. 
4) Tortous T-tube tract. 
5) Inability to fragment large stone(>7mm) 
Complications: 
• Sinus tract perforation 
• Bile leak 
• Cholangitis 
• Pancreatitis 
LAPROSCOPIC APPROACH TO CBD STONES: 
       The treatment of CBD stones was relatively straight forward until the advent 
of  laproscopic  cholecystectomy in 1989. Laproscopic exploration of the CBD 
enables appropriate patients to undergo complete management of the calculous 
biliary tact disease with one invasive procedure.This modality of treatment is ideal 
for patients with CBD stones identified during intra op cholangiography or in 
patients with preop suspected suspected CBD stone managed at centers where 
laproscopic CBD explorations are routinely performed.There are two approaches 
for Laproscopic CBD exploration:Transcystic duct bile duct exploration and 
Laproscopic choledochotomy.  
Laproscopic Transcystic duct bile duct exploration: 
               This technique involves  blunt dissection of the cystic duct down to its 
junction with the CBD.A cystic ductomy is made and a guide wire inserted into the 
bile duct. A cholangiocatheter can then be advanced over the guide wire into the 
bile duct and saline irrigated through the catheter in an attempt to flush small 
stones out of the bile duct .If the stones are larger than the lumen of the cystic duct 
;cystic duct is dilated with a balloon catheter. Stone retrieval baskets can then be 
inserted to extract stones under fluoroscopy. To document stone clearance a 
completion cholangiogram should be performed. A cystic duct drainage tube can 
be left in place if there are equivocal findings on cholagiogram. Later radiological 
extraction of the retained stones through the tract can be done. 
Laproscopic Choledochotomy: 
                          A longitudinal choledochotomy is made on the anterior wall below 
the cystic duct. The choledochotomy should be as long as the  diameter of the 
largest stone.Stones are extracted using baskets or balloon. Choledochotomy is 
then closed over 4-O PDS sutures. This procedure requires skill to close the 
choledochostomy. 
                  Clearance of all CBD stones is achieved in 75% to 95% of patients with 
laproscopic CBD exploration.Complications of lap CBD exploration include: 
Biliary leak, disloged T-tube,biliary sticture, subhepatic fluid collection and 
damage to surrounding viscera. 
 
 
 
                            3.METHODOLOGY    
               The present study was carried out in patients with obstructive jaundice 
due to choledocholithiasis between June  2011 to December 2013 in Rajiv Gandhi 
Government General hospital attached to Madras Medical College. 
               Totally 50 patients with jaundice due to  choledocholithiasis were 
included in the study.  All the 50 patients were treated  with  either  ERCP or with  
open  surgery. Outcome of  both  the procedures were compared.  
  Types of outcome measures 
1. Mortality at 30 days and at maximum follow-up. 
2.Morbidity- Complications from surgery and procedures such as bile duct injuries, 
pancreatitis, cholangitis, pulmonary/cardiac/   renal complications. 
3.Duct clearance as determined by cholangiogram at the time of intervention, lack 
of symptoms, signs or abnormal biochemistry/ liver function tests. 
4.Number of procedures. 
5. Duration of operation and/or procedure(s). 
6.Duration of hospital stay. 
                   All the above measures were compared between the two groups. 
         Detailed clinical history and examination were performed in all cases as per 
the proforma. Diagnostic investigations – ultrasonography abdomen, LFT were 
done in all cases. Perop cholangiogram was selectively used when USG was 
negative for CBD stones, but history and biochemical parameters were suggestive 
of CBD stones. 
           Procedural investigations like Hb%, coagulation profile, TC, DC, RBS, 
Blood urea, serum creatinine, chest X ray and ECG were performed in all cases. 
Bile cultures were obtained in all cases. 
 INCLUSION CRITERIA: 
1.All the cases of Common bile duct stones  
2. CBD stones complicating as obstructive jaundice, cholangitis, pancreatitis. 
EXCLUSION CRITERIA: 
1. Patients with ductal obstruction due to malignant diseases.  
         All patients were screened for any coagulopathy and treated appropriately 
with Vitamin K or fresh frozen plasma depending upon the severity and urgency of 
the procedure.Pre op vitamin K was given to all patients. All patients were 
adequately hydrated and flushed with mannitol to prevent hepatorenal syndrome.  
           For open surgery with T-tube closure; discharge was done after the 10th day 
T-tube cholangiogram was negative for stones and dye in the duodenum was 
present. Patients with biliary enteric anastomosis were discharged when they were 
taking oral diet, feeling symptomatically better and the suture wound had 
healed.Some patients with surgical site infection had extended stay till the surgical 
wound was dry and healing. Patients who had undergone ERCP were discharged 
when  symptomatically better and taking oral diet . 
          Closed suction drains were used in all open and laparoscopic CBD 
exploration cases. It was kept in subhepatic space and removed after 48 hrs or 
when the collection was non bilious and less than 30 ml in 12 hrs.All patients were 
followed up on out patient basis with repeated assessment of patients’ symptomatic 
status, physical exam, liver function tests and abdominal ultrasonography. The 
interval of follow was 1 week, 2 weeks, 1 month, 2 months,6 months, 12 months, 
18 months and 24 months. 
                 Statistical analysis in the form of percentages, means, confidence 
intervals,standard deviations, sensitivity, specificity, positive predictive value were 
calculated to analyze the significance of the diagnostic investigations and the 
impact of the therapeutic procedures. The statistical software SPSS 11.0 was used 
for analysis of data, Microsoft word and Excel were used to generate graphs and 
tables. 
 
           
 
 
                       
                            5. RESULTS 
                                          TABLE  1 
                               Age distribution with gender   
Age in years Male Female Total 
<30 3(6%) 2(4%) 5(10%) 
30-40 2(4%) 4(8%) 6(12%) 
40-50 5(10%) 9(18%) 14(28%) 
50-60 5(10%) 10(20%) 15(30%) 
>60 4(8%) 6(12%) 10(20%) 
Total 19(38%) 31(62%) 50(100%) 
Mean 47.84 54.76 51.30 
     
Age at incidence: 
             Age of the patients varied from 21 t0 74 years. Mean age for male was  
47.84 years and female was 54.76 years. Mean age was 51.30 years. Highest 
incidence was noted in the age group between 50 and 60 years and lowest 
incidence less than 30 years. 
Sex incidence: 
              Out of the 50 patients 19(38%) were males and 31(62%) were females. 
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                                          TABLE 2 
Incidence of CBD Stone in Relation to GB Stone Incidence. 
Type of stone Number of cases 
GB stone 784 
CBD stone 50 
      
   CBD Stone patients as a % of GB Stone patients - 6.37% 
 
                                GRAPH 3 
 Incidence of CBD Stone in Relation to GB Stone Incidence.          
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                                 TABLE 3 
                         Duration of Hospital stay.                                  
Duration of hospital stay in days Number 
n=50 
% 
1 to 7 -  
8 to 14 15 30 
15 to 21 26 52 
>21 9 18 
Mean = 18.3 days   
 
Duration of Hospital Stay:  
                  15 patients (30%) stayed in the hospital for a duration  ranging from 8 
to 14 days. 26 patients (52%) stayed for a period of 15 to 21 days, 9patients stayed 
or more than 21 days and  no patient was discharged prior to 7 days of admission.          
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                                       TABLE 4   
                            Presenting symptoms 
Presenting symptom Number n=50 % 
Pain 44 88 
Jaundice 30 60 
Fever 7 16 
Pancreatitis 2 4 
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  Presenting Symptoms.  
                 Pain abdomen was  present in 44 patients(88%). Severe pain abdomen 
radiating to the back, suggesting pancreatitis was present in 2 patients (4). Jaundice 
was present in 30 patients(60%) and Fever was present in 7patients (14%). 
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                                         Presenting symptoms 
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                                               TABLE 5 
                                              Past History 
Past History Number  n=50 % 
Jaundice 6 12 
Fever 12 24 
DM 15 30 
HTN 11 22 
Past History.  
           6 patients (12%) had documented past history of jaundice, relieved by 
temporary biliary stent before inclusion in our study. 12 patients (24%)) had 
recurrent attacks of fever with chills and rigors, suggestive of cholangitis. The 
most common co-morbid medical illness was DM (30%) followed by HTN (22%)     
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0
2
4
6
8
10
12
14
16
Jaundice Fever DM HTN
No. of patients
                                 LAB FINDINGS 
                                     TABLE 6 
                                Total Biluribin 
Total Bilirubin(mg%) Number n=50 % 
≤ 1 8 16 
>1 - 2 7 14 
>2 - 4 15 30 
>4-6 9 18 
>6 11 22 
                  Mean = 3.86 mg%; SD = 1.7026 
                35(70%) patients had clinical evidence of jaundice (icterus) because their 
total bilirubin values exceeded the clinical threshold of 2 mg%.Most of the patients 
had values between 2 to 4 mg% with highest value obtained of 15.6mg%. 
                                                GRAPH 7 
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                                   TABLE 7 
                            Conjugate Biluribin 
Conjugate Biluribin 
mg% 
Number n=50 % 
0.3 – 1 8 16 
>1-3 17 34 
>3-5 13 26 
>5 12 24 
                     Mean = 2.054 mg%; SD = 1.04 
 The mean conjugate bilirubin obtained was 2.054mg%. Most of the patients had 
values ranging from 1 to 3 mg%.                                                         
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                                                 TABLE 8 
                                       Alkaline Phosphatase 
Alkaline phosphate IU/L Number n=50 % 
130 to 150 7 14 
>150 to 250 19 38 
>250 to 350 8 16 
>350 to 450 7 14 
>450 to 550 6 12 
>550 3 6 
Mean = 273.2 IU/L; SD = 121 
     All patients had raised alkaline phosphatase. Even in 7 cases (14%)where total 
bilirubin was normal, alkaline phosphatase was raised, suggesting cholestasis. 
Mean alkaline phosphatase was 273.2 IU/L. Most patients had values between 151 
to 250 IU/L. 
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                                          TABLE 9 
                    Ultrasonography Abdomen – Gall Bladder 
Findings Number n=50 % 
Normal GB 3 6 
Wall thickening 44 88 
Stones 43 86 
Sludge 2 4 
No Gall Bladder 3 6 
Dilatation of IHBR 36 72 
             44 patients (88%) had thickened/contracted gall bladder suggestive of 
chronic cholecystitis. Similarly either sludge or stones were present in 45 
patients(90%).3 patients(6%) had a sonologically normal gall bladder with CBD 
stones which was later confirmed to be primary CBD stones.3 patients (6%) had 
undergone cholecystectomy earlier.                     
                                       GRAPH 10 
                 Ultrasonography of abdomen : Gall Bladder 
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                                          TABLE 10 
              Ultrasonography of abdomen- CBD Diameter 
CBD diameter in mm Number n=50 % 
≥ 8 to <10 9 18 
10 to <12 14 28 
12 to <14 7 14 
14 to < 16 11 22 
16 to <18 4 8 
18 to <20 3 6 
≥20 2 4 
                     Mean = 15.32; SD = 4.86 
              The mean CBD diameter was 15.32 mm with most patients having CBD 
diameter either between 10 to 12 mm(28%).The highest recorded CBD diameter 
was 25mm. 
                                           GRAPH 11   
                                 CBD Diameter in mm   
 
0
5
10
15
≥8 to <10 10 to <1212 to <1414 to <1616 to <1818 to <20 ≥20 
No. of patients
                                            TABLE 11 
               CBD Calculi as in Ultrasonography of abdomen 
Stones Number n=50 % 
Multiple 36 72 
Single 8 16 
False Negative  3        6 
Sludge  3 6 
          44 patients(88%) had sonological evidence of stones in the CBD. 3(6 %) 
cases had false negative sonology of the CBD for stones which was confirmed with 
per op cholangiogram in 2 cases and by MRCP in one case.                           
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                                CBD calculi    
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                                            TABLE 12 
                                         Bile Culture 
Bile culture Number n=50 % 
E.coli 32 64 
Klebsiella 9 18 
Enterococcus faeclis 3 6 
No growth 6 12 
              Most common organism isolated was E.coli (64%) cases. 6patients (12%) 
had no evidence of any growth despite of culturing for 48 hrs on both aerobic and 
anaerobic culture media. Klebsiella was grown in about 9 patients (18%). 
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                                   TABLE 13 
                          Per Op Cholangiogram 
Pre Clearance Per Op 
Cholangiogram 
Number n=3 % 
Stones visualised 3 100 
Stones not visualised 0 - 
Specificity  100 
 
Post Clearance Per Op 
Cholangiogram 
Number n=6 % 
Filling defect(stone) 0 0 
Flow into duodenum 5 83.33% 
Specificity  83.33% 
      
   Per op cholangiogram was used in 3 cases with negative USG for CBD stones 
and had specificity of 100%.However per op cholangiogram was false positive in 1 
case in post exploration cholangiogram bringing its specificity to 83.33% in this 
scenario. 
                                                                            
                                                TABLE 14 
                                                    ERCP 
Result Number n=16 % 
Stone visualisation 16 100 
Successful clearance 11 68.75 
Incomplete clearance 
when stent in situ 
5 31.25 
Post ERCP pancreatitis 2 12.5 
 
          ERCP had success of clearing the CBD of all the stones in 68.75% of the 
cases. It failed in 5 cases (31.25%) for which a temporary stent was left followed 
by open CBD exploration.2 patients(12.5%) developed post ERCP pancreatitis.  
                                      GRAPH 14 
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                                             TABLE 15 
                                         Open Surgery 
Procedure Number n=39 % 
CBDE+ T- Tube closure 34 87.18 
CBDE+ choledochoduodenostomy 4 10.26 
CBDE+choledochojejunostomy 1 2.56 
Hepaticojejunostomy - - 
                  39 patients were subjected to open CBD exploration which also include 
5 failed cases of ERCP. 34 patients (87.18%) underwent CBDE with T-tube 
closure. 4 patients (10.26%) underwent choledochoduodenostomy . 1 case(2.56%) 
underwent choledochojejunostomy  as the patient had a scarred duodenum from 
acid peptic disease and had undergone Gastrojejunostomy earlier.                              
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                                        TABLE 16 
                      Complications of open surgery 
Complication Number n=39 % 
SSI 7 17.94 
Bile leak 1 2.56 
LRTI 4 10.25 
Retained stone 0 0 
                     Mortality- 0% Morbidity- 30.75% 
               7 patients (17.94%) developed infection of surgical wound as a result of 
contamination from the biliary tract. Bile leak was seen in 1patient (2.56%) due to 
T-tube dislodgement. 4 patients (10.25%) developed lower respitory tract infection 
(LRTI). 
 
              
 
 
 
 
 
 
                                          TABLE 17 
                                      FOLLOW UP  
Duration (months) Number n=50 % 
Till date 34 68 
Upto 24 months 0 0 
Upto 18 months 2 4 
Upto 12 months 4 8 
Upto 6 months 3 6 
Upto 2 months 2 4 
Lost after discharge 5 10 
             68 % (34 patients) have been followed up till the time of submission of this 
study. 14% (7 cases) were lost from follow up after 2 months of surgery. 
                                 GRAPH 17 
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                                         TABLE 18 
                            OVERALL MORBIDITY 
Morbidity % 
Open Surgery 30.57 
ERCP 12.5 
Mortality 0 
 
          While mortality is nil in both open and ERCP procedures the post operative 
morbidity of open procedure was more when compared to ERCP. 
                      
                                
 
 
 
 
 
 
 
 
 
                                        TABLE 19 
                                FAILIURE  RATE 
Procedure Number of cases % 
Open surgery 0 0 
ERCP 5 31.25 
 
        Out of 16 patients who had undergone ERCP, incomplete clearance of the 
CBD or retained stones found in 5 patients (31.25%) . These patients had 
undergone open surgery after ERCP for complete clearance of the duct. 
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                          5.DISCUSSION 
             Common bile duct stones are present in approximately 5% of patients 
undergoing elective cholecystectomy and 10% of patients with acute cholecystitis. 
No single blood investigation or combination of blood investigations can predict 
whether or not a common bile duct stone is present.  
               Intraoperative  cholangiography is the gold standard of diagnosis but 
CBD stone can be diagnosed preoperatively with ultrasound, ERCP, or magnetic 
resonance cholangiopancreatography.If choledocholithiasis is diagnosed 
preoperatively, several different modalities can be utilized. The factor that 
determine the optimal approach include patient’s age and condition, the presence 
of jaundice or cholangitis and size of the duct and stone.Hence, algorithm for 
managing these patients will vary from one locale to another. There are specific 
conditions that mandate CBD open exploration and therefore the practicing 
surgeon must be well versed in those techniques. 
              The natural history of choledocholithiasis is unpredictable. Small stones  
may pass spontaneously into the duodenum without causing symptoms, or they 
may obstruct the pancreatic duct temporarily, induce an episode of pancreatitis, 
and pass into the duodenum with relief of symptoms. Stones that do not pass into 
the duodenum may reside in the bile duct for long, symptom free periods, then 
suddenly precipitate an episode of jaundice or cholangitis . 
         The study was conducted in the Department of General Surgery under 
madras Medical College . We have the essential infrastructure for open surgical 
management for CBD stones and  endoscopic  infrastructure. Through this study, it 
was aimed to describe the disease and develop a management protocol for patients 
with CBD  stones in our setting. The present study has been carried out on patients 
who were admitted with CBD stones in Rajiv Gandhi Government General 
Hospital, Chennai from June 2011 to December 2013. Detailed clinical history and 
examinations were performed in all cases. Diagnosis of CBD stone  causing 
jaundice was arrived at on the basis of abdominal ultrasonography and blood 
investigations. Selected  cases were subjected to per operative cholangiography 
and ERCP based on their merit. Patients underwent relevant blood investigations – 
Hemoglobin, TC, DC, RBS, blood urea, Serum createnine, Liver function test. 
Patients with abnormal bleeding, clotting time were subject to further evaluation 
using PT, aPTT. Bile culture and sensitivity were done for all cases. 
         Protocol was followed and patients were followed up, complications were 
studied.  
 
 
 
 
Incidence of Disease 
             During the study period, 784 cases of documented cholelithiasis were 
admitted out of these 50 had evidence of common bile duct stones. Thus incidence 
of CBD stone in milieu of cholelithiasis was 6.37%. 
According to Gerard, the overall incidence of CBD stones was 8% of the 
cases with cholelithiasis. 
Age Incidence 
          Age of the patients varied from 21 to 74 yrs.  Mean age for male was  47.84 
years and female was 54.76 years. Mean age was 51.30 years. Highest incidence 
was noted in the age group between 50 and 60 years and lowest incidence less than 
30 years. 
        In the study conducted by Gerard RM 61 (2000) maximum incidence was 
seen in age group between 50 – 59 yrs (20.1%).  
Sex incidence 
           The female to male ratio was 1.6. According to Gerard RM 61 (2000), the 
female to male ratio was 1.72. 
Duration of Hospital Stay 
            Mean duration of stay was 18.3 days. This was because of 
choledochotomy closure in all except cases which underwent complete stone 
clearance by ERCP or biliary enteric drainage were done on a T-tube. According to 
Marwahs et al (2004) mean hospital stay was 4.4 days with primary 
choledochotomy closure and 15.4 days with closure on T – tube.  
 Presenting Symptoms 
    Pain was the most common symptom. Pain abdomen was  present in 44 
patients(88%). Severe pain abdomen radiating to the back, suggesting pancreatitis 
was present in 2 patients (4%). Jaundice was present in 30 patients(60%) and Fever 
was present in 7patients (14%).  
     According to Wani NA et al, 94% had pain in the right upper abdomen. 
According to Acosta JM et al (1974)65, gall stones are responsible for 50% of all 
cases of pancreatitis. Conversely, 4 – 8% of patients with gall stones develop 
pancreatitis. This was in accordance to our study of pancreatitis in 2 cases (5.8%). 
Clinical jaundice was present in 16 patients (45.7%) with positive predictive value 
of  64%. This was roughly in accordance to meta-analysis by Abboud66 (1996) et 
al which showed jaundice having positive predictive value of 39% for 
choledocholithiasis. 
Past History 
           6 patients (12%) had documented past history of jaundice, relieved by 
temporary biliary stent before inclusion in our study. 12 patients (24%)) had 
recurrent attacks of fever with chills and rigors, suggestive of cholangitis. The 
most common co-morbid medical illness was DM (30%) followed by HTN (22%) 
    The specificity of cholangitis in predicting CBD stone was 100% but its  
sensitivity could not be calculated as no case where history suggestive of 
cholangitis was present and there was no CBD stone. Fever and pain abdomen may 
be also due acute cholecystitis but when present with chills and rigors with features 
of cholestasis; it goes in favour of cholangitis. 
             According to Abboud BA  et al (1996) the specificity of cholangitis  in 
predicting CBD stones was 99%. 
ANALYSIS OF LAB INVESTIGATIONS 
Serum Total Bilirubin 
                35(70%) patients had clinical evidence of jaundice (icterus) because their 
total bilirubin values exceeded the clinical threshold of 2 mg%.Most of the patients 
had values between 2 to 4 mg% with highest value obtained of 15.6mg%. 
             The sensitivity of elevated bilirubin in predicting CBD stones in our study 
was 91.2%. This is more than study done by Abboud66 et al (1996) of 69% 
sensitivity probably due to advanced presentation of cases with prolonged and 
significant cholestasis.  
      The most common group was between 2 to 4 mg% (30%) which is in 
accordance with Lawrence  et al (2003) which says that absolute level usually 
remain under 10 mg/dl and most are in the range of 2 – 4 mg/dl. Also, in all cases 
the direct (conjugated) fraction exceeded indirect which is also in accordance with 
Lawrence 35 et al (2003). 
Alkaline Phosphatase 
               All patients had raised alkaline phosphatase. Even in 7 cases (14%)where 
total bilirubin was normal, alkaline phosphatase was raised, suggesting 
cholestasis.Mean alkaline phosphatase was 273.2 IU/L. Most patients had values 
between 151 to 250 IU/L.  Even in cases where total bilirubin was normal  there 
was elevation of alkaline phosphatase which is in accordance with Lawrence et al 
(2003) which states that serum alkaline phosphatase level usually rises and may be 
the only chemical abnormality in patients without jaundice; when the obstruction 
is relieved, the alkaline phosphatase and bilirubin should return to normal within 
1– 2 weeks with the exception that the former may remain elevated longer if the 
obstruction was prolonged. 
ANALYSIS OF IMAGING MODALITIES 
Abdominal Ultrasonography : 
Gall Bladder 
             46 patients (92%) had thickened/contracted gall bladder suggestive of 
chronic cholecystitis. Similarly either sludge or stones were present in 45 
patients(90%).3 patients(6%) had a sonologically normal gall bladder with CBD 
stones which was later confirmed to be primary CBD stones.3 patients (6%) had 
undergone cholecystectomy earlier. Our incidence of primary CBD stone was 
2.9% which is lower than that quoted by Saharia1 et al (1974) of 4%. This is 
because of small size of the study than Saharia.The abdominal USG was able to 
detect gall stones in gall bladder in all cases (100%) which is in agreement with 
Zinner MJ et al (1997) which states that the presence of associated gall bladder 
stone can be confirmed >98% of patient with gall stones and dilation of the 
intrahepatic biliary system can be identified in most. 
CBD 
     All patients had CBD ductal diameter of greater than or equal to 8 mm.The 
mean CBD diameter was 15.32 mm with most patients having CBD diameter 
either between 10 to 12 mm(28%).The highest recorded CBD diameter was 25mm. 
The specificity of USG for CBD stone was 
100% which correlates with Abboud BA et al (1996). The specificity of USG was 
confirmed either with ERCP/per operative cholangiography or intraop assessment 
of the CBD. 
BILE CULTURE 
        Bile was routinely cultured.  Most common organism isolated was E.coli 
(64%) cases. 6patients (12%) had no evidence of any growth despite of culturing 
for 48 hrs on both aerobic and anaerobic culture media. Klebsiella was grown in 
about 9 patients (18%). 
The above findings are in partial agreement with that of Wani NA et al (1991) who 
observed the following:E. coli (72.7%), Klebsiella (18.8%) and Sterile (33.3%). 
 ERCP 
A total of 16 patients were subjected to ERCP in our study.The Specificity of 
ERCP in confirming CBD stones was 100%, which 
compares with that of Frey et al (1982) of 98%. Sensitivity could not be 
determined as ERCP was only selectively used. All patients underwent ERCP with 
endoscopic sphincterotomy and stone extraction by either Dormia basket or 
Fogarty balloon. The success of ERCP in clearing the CBD of stones was 11 out of 
16 cases (68.75%), which is in agreement with Freeman M et al (1996), which 
states that complete clearance of all CBD stones is achieved endoscopically in 71-
75% of the patients with the first procedure and 84 – 95% of the patients with 
multiple endoscopic procedures. 
Complications of ERCP 
1) Incomplete clearance – 5 cases (31.25%) 
2) Post ERCP pancreatitis – 2 cases (12.5%) 
              The rates of post ERCP pancreatitis varies from less than 1% to 40%. The 
difference in criteria for determining pancreatitis, method of data collection and 
patient population (i.e., number of high risk patients included in the published 
series) are factors likely to affect post ERCP pancreatitis. According to Abdel 
Aziz, et al 2007 May. The consensus conference identified pain persisting for 
24hrs, associated with hyperamylasemia greater than 3 times the upper limit, as an 
indicator of pancreatitis (Testoni PA, 2002 Nov.).Our case had a pre ERCP 
amylase of 52 IU/L (normal range 28 to 100 IU/L) and post ERCP amylase at 24 
hrs of 1072 IU/L, which fits into the criteria for post ERCP pancreatitis. The rate 
impaction of dormia basket is very rare,between 0.3 to 1%2. 
                              
  C-arm image of ERCP showing successful clearance of CBD calculi 
                       
                           Endoscopic sphincterotomy 
PEROP CHOLANGIOGRAM 
Only selective cholangiography was performed. Two methods were followed: 
1) Trancystic for for pre exploration cholangiogram. 
2) Through T – tube after cholodochotomy for post exploration 
cholangiogram. 
 Our indication for cholangiography was: 
1) Abdominal USG negative for CBD stones, but history and lab data suggestive of 
CBD stones (serum bilirubin more than 3mg%, elevated serum amylase, history of 
cholangitis, pancreatitis). 
2) Post-exploration to confirm complete clearance of CBD stones especially when 
multiple stones were retrieved from CBD, but CBD diameter was not sufficient for 
biliary enteric drainage (<1.2 Cms). 
Pre-explorative cholangiogram was possible for CBD stones in all cases.  
Mulholland  et al 2006, which states that if intra-operative cholangiography is 
selectively used for the following: 
• A dilated CBD 
• A wide cystic duct 
• Palpable CBD stones 
• Elevated LFT 
• History of cholangitis, pancreatitis 
Approximately 30% of the patients will require intraop cholangiogram at 
the time of cholecystectomy. Cholangiography was accurate in 100% of the cases 
in our studies compared to Gerard et al 2000, of 88%. 
                            
                                           
                                                     
Per op post-exploration cholangiogram showing flow of dye into the  
Duodenum                                                                   
 
TREATMENT 
Out of 50 patients, 16 patients underwent ERCP (32%). ERCP was 
successful in clearing CBD of stones in 11 cases (68.75%). In 5 cases, temporary 
stent was introduced due to incomplete clearance in which open CBD exploration 
was carried out. The total number open CBDE was 39 (68%). 
 
 
 
OPEN CBD EXPLORATION: 
Procedure Present Study Other Study  
(n = 39) (n = 1132) 
1. CBDE + T-tube closure       -34(87.18 %) 1050 (92.8%) 
2. CBDE + trasnsduodenal      - 0 (0%) 45 (4%) 
                   sphincteroplasty. 
3. CBDE + Choledocho            - 4 (10.26%) 35 (3%) 
                   duodenostomy 
4. CBDE + choledocho             - 1 (2.56%) 0 (0%) 
                   jejunostomy. 
5. Hepaticojejunostomy            - 0 (0%) 2 (0.02%) 
While CBDE with T-tube drainage remained the most common procedure used in 
open CBD exploration; the biliary enteric drainage procedure of choice in  our 
cases was choledochodudenostomy. Transduodenal sphinctrotomy was avoided as 
the same could be done endoscopically via ERCP.Choledochodudenostomy was 
used when the CBD was dilated (at least 12 mm,but preferred diameter was 20 mm 
and was associated with multiple stones, biliary sludge impacted, giant stones, 
ampullary stenosis, which is in accordance with the indications given by Blumgart  
et al 2007. One  patient (2.56%) underwent Roux-en-y choledochojejunostomy, as 
one patient had post gastro jejunostomy status, done for peptic ulcer disease. 
Patient had a CBD of 20 mm with multiple stones and pyloric stenosis. Hence 
choledochoduodenostomy could not be attempted because of duodenal scarring. 
Overall as a part of biliary enteric drainage choledochoduodenostomy was 
choosen. This is in accordance with Schein and Gliedmann 1981 which states that 
choledochoduodenostomy is a safe and simple operation with low morbidity and 
mortality especially in elderly patients than transduodenal sphincteroplasty . 
              
                                  Needle cholodochotomy 
 
            
         Perop trancystic cholangiographic catheter in situ 
 
          
                            Open cholodochotomy with stone in situ 
 
         
                              Choledochotomy closure on T-tube 
                         
                10th day T-tube cholangiogram with free flow of bile into duodenum 
COMPLICATIONS 
1. ERCP 
a) Incomplete clearance – 5 cases (31.25%) 
b) Post ERCP pancreatitis – 2 cases (12.5%) 
Further discussion about the complication of ERCP has been dealt in Diagnostic 
ERCP section.                  
2. Open CBD Exploration: 
a) Wound infection – 7 cases (17.94%) 
b) Bile leak – 1 case (2.56%) 
c) Chest infection – 4 cases (10.25%) 
d) Retained stone – 0 case (0%) 
Morbidity: 30.75%  
Mortality: 0% 
Wound infection: 
7 cases developed wound infection 3rd post op day onwards. As already elucidated 
in Bile Culture section; infected wounds cultured Klebsiella , 
Enterococus . This led to extended hospitalization of 8 days on the 
average, and 2 cases needed secondary suturing of the wound. 
Factors predisposing to infections were: 
a) Grossly dilated CBD with multiple stones – 5 cases  
b) Isolation of Klebsiella and Enterococus in bile culture – 7 cases (100%) 
c) Gross contamination of the operating field on open choledochotomy, 
converting the wound from clean to clean contaminate – 5 cases. 
d) History of cholangitis -4 cases. 
Bile Leak 
1 case (2..56%) developed bile leak because of partial dislodgement of T – tube on 
post-operative day 8, due to the tugging of the T – tube by the patient. The position 
of the T- tube was confirmed by T-cholangiogram. Since dye was extravasating 
into the peritoneal cavity and there was no evidence of residual stone, the T – tube 
was removed. 
Lower Respiratory Tract Infection (LRTI) : 
Two cases developed atelectasis followed by lower respiratory tract infection due 
to the pain of the open surgical wound. The patients were managed with chest 
physiotherapy and antibiotics. There was no increase in the length of 
hospitalization due to the above complication. 
Retained Stones:  
         None of the cases had residual stones post procedure or on the 
tenth day T-tube cholangiogram. This is because 
1) Use of biliary-enteric drainage when multiple stones or CBD dilated over  cms 
was present. 
2) Confirmation of ductal clearance using perop cholangiogram in doubtful cases. 
Though our morbidity of 25% is higher than that of Girard and Morin 1993 of 17% 
but the most frequent complications by them of retained stones, bile leak, wound 
complications are in line with our study, except for retained stones. 
FOLLOW UP: 
         All patients were followed up on out patient basis with repeated 
assessment of patients symptomatic status, physical exam, liver function tests and 
abdominal ultrasonography.68% (34 patients) have been followed up till the time 
of submission of this study. 14.% (7cases) were lost from follow up after 2 months.  
Overall Morbity And Mortality: 
While mortality is nil in both open and ERCP procedures the overall morbidity of 
open procedure was more accounting for 30.75%  than ERCP12.5 % . 
0 % Mortality in open CBD exploration (Pappas et al, 1990) and endoscopic 
(Shivak 1989), laparoscopicCBD (Petelin,1993) have been recorded which is in 
agreement with our study. 
Failiure rate: 
    Out of 16 patients who had undergone ERCP, incomplete clearance of the CBD 
or retained stones found in 5 patients (31.25%) . These patients had undergone 
open surgery after ERCP for complete clearance of the duct. Failiure rate of ERCP 
is more when compared to open CBD exploration. 
                               7. SUMMARY 
                   The study was conducted during the period from June 2011 to 
December 2013 at Rajiv Gandhi Government General Hospital,Chennai 
attached to Madras Medical College.A prospective clinical descriptive study 
consisting of 50 patients was taken.  The mean age for male was 47.84 yrs and for 
female, it was 54.76 yrs. The highest incidence was noted in the 51 – 60 yrs age 
group. Lowest incidence was in the  <30 yrs age group. The female to male ratio 
was 1.6 CBD stones were found in 6.37% of the cases with Gall Bladder stones. 15 
patients (30%) stayed in the hospital for a duration  ranging from 8 to 14 days. 26 
patients (52%) stayed for a period of 15 to 21 days, 9patients stayed or more than 
21 days and  no patient was discharged prior to 7 days of admission. 
    Pain abdomen was  present in 44 patients(88%). Severe pain abdomen radiating 
to the back, suggesting pancreatitis was present in 2 patients (4). Jaundice was 
present in 30 patients(60%) and Fever was present in 7patients (14%). 
           6 patients (12%) had documented past history of jaundice, relieved by 
temporary biliary stent before inclusion in our study. 12 patients (24%)) had 
recurrent attacks of fever with chills and rigors, suggestive of cholangitis. The 
most common co-morbid medical illness was DM (30%) followed by HTN (22%) 
        35(70%) patients had clinical evidence of jaundice (icterus) because their total 
bilirubin values exceeded the clinical threshold of 2 mg%.Most of the patients had 
values between 2 to 4 mg% with highest value obtained of 15.6mg%. 
   All patients had raised alkaline phosphatase. Even in 7 cases (14%)where total 
bilirubin was normal, alkaline phosphatase was raised, suggesting 
cholestasis.Mean alkaline phosphatase was 273.2 IU/L. Most patients had values 
between 151 to 250 IU/L. 
          44 patients (88%) had thickened/contracted gall bladder suggestive of 
chronic cholecystitis. Similarly either sludge or stones were present in 45 
patients(90%).3 patients(6%) had a sonologically normal gall bladder with CBD 
stones which was later confirmed to be primary CBD stones.3 patients (6%) had 
undergone cholecystectomy earlier. 
          All patients had CBD ductal diameter of greater than or equal to 8 mm.The 
mean CBD diameter was 15.32 mm with most patients having CBD diameter 
either between 10 to 12 mm(28%).The highest recorded CBD diameter was 25mm. 
The specificity of USG for CBD stone was 100% which correlates with Abboud 
BA et al (1996). The specificity of USG was confirmed either with ERCP/per 
operative cholangiography or intraop assessment of the CBD. 
       Most common organism isolated was E.coli (64%) cases. 6patients (12%) had 
no evidence of any growth despite of culturing for 48 hrs on both aerobic and 
anaerobic culture media. Klebsiella was grown in about 9 patients (18%). 
         Per op cholangiogram was used in 3 cases with negative USG for CBD 
stones and had specificity of 100%.However per op cholangiogram was false 
positive in 1 case in post exploration cholangiogram bringing its specificity to 
83.33% in this scenario.   
      ERCP had success of clearing the CBD of all the stones in 68.75% of the cases. 
It failed in 5 cases (31.25%) for which a temporary stent was left followed by open 
CBD exploration.2 patients(12.5%) developed post ERCP pancreatitis. 
        39 patients were subjected to open CBD exploration which also include 5 
failed cases of ERCP. 34 patients (87.18%) underwent CBDE with T-tube closure. 
4 patients (10.26%) underwent choledochoduodenostomy . 1 case(2.56%) 
underwent choledochojejunostomy  as the patient had a scarred duodenum from 
acid peptic disease and had undergone Gastrojejunostomy earlier. 
       68% (34 patients) have been followed up till the time of submission of this 
study. 14.% (7cases) were lost from follow up after 2 months.  
   While mortality is nil in both open and ERCP procedures the overall morbidity 
of open procedure was more accounting for 30.75%  than ERCP12.5 % .0 % 
Mortality in open CBD exploration . 
    Out of 16 patients who had undergone ERCP, incomplete clearance of the CBD 
or retained stones found in 5 patients (31.25%) . These patients had undergone 
open surgery after ERCP for complete clearance of the duct. Failiure rate of ERCP 
is more when compared to open CBD exploration. 
                               
                             
 
 
 
 
 
 
 
 
 
 
                       8. CONCLUSION 
          The management of CBD stones has been subject to much debate during 
the past several years, especially with the advent of new laparoscopic techniques 
and greater expertise of endoscopic procedures. This study was undertaken to get a 
clinical perspective of CBD stones in the milieu of GB stones and to determine the 
optimal approach for the management with the age of the patient, general 
condition, complicating factors,  availability of endoscopy and minimally invasive 
procedure, determining the algorithm of treatment. The end result of our study was 
the developing of a management protocol in our setting. 
 CBD stones were present in 6.37% of gall bladder stone cases encountered.  
 There was a steady rise of incidence of CBD stones beyond the age of 55 
yrs with female patients outnumbering the males.  
 Patients spent an average of 18.3 inpatient days for the treatment of CBD 
stones. 
 Elevated bilirubin was a positive predictor of CBD stones in 88.2% of the 
cases. Elevated alkaline phosphatase was a further confirmatory index of 
cholestasis.         
  Transabdominal ultrasonography was the imaging modality commonlyused 
to detect CBD stones, as it was cost efficient, easily available, able to detect 
gall bladder stones in all our cases and CBD stones in 91% of our cases. It 
was also used to measure CBD diameter which helped us to individualize 
the management based on it. 
 Perop cholangiogram was used selectively when USG was doubtful of CBD 
stones, yet history and biochemical parameters suggestive of it. It was also 
used when confirmation of complete clearance of CBD of the stones was 
necessary peroperatively in order to avoid any biliary enteric drainage, 
because of insufficient ductal diameter for the same. 
 Patients with CBD stones with acute biliary pancreatitis,cholangitis needing 
immediate decompression of CBD, patient who had already undergone 
cholecystectomy and patients with minimally dilated CBD where open 
exploration would have carried greater morbidity were subjected to ERCP. 
 Bile culture in our cases revealed E.coli as the most common organism, but 
in relation to complications in terms of post-op wound infection, 
cholangitisklebsiella, enteroccocus out numbered E.coli. Our most common 
treatment modality was open CBD exploration with closure of  
choledocotomy on T-tube being the most common procedure. 
 Biliaryenteric drainage in the form of choledochoduodenostomy, 
choledochojejunostomy was done in selective cases. Open CBD exploration 
was the last resort for failed minimally invasive treatment, like ERCP and lap 
CBD exploration. The benefit of open CBD exploration exceeded its morbidity 
with zero mortality in well chosen cases. 
     To conclude, there can be no definite algorithm for the management of CBD 
stones as the patients’ age, underlying general condition being the only 
standardizable factor with facilities for endoscopic, laparoscopic management 
being variably available from institution to institution and hence, necessitating 
tailoring the management of CBD stones depending upon the Institution’s 
resources. 
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                                      10. ANNEXURES 
 
PROFORMA 
NAME                                                                        IP NO 
AGE                                                                            DOA 
SEX                                                                             DOS 
ADDRESS                                                                  DOD 
PRESENTING COMPLAINTS 
Pain Abdomen                   Right upper quadrant pain 
                                              Radiation to back 
Jaundice                                     pale stools 
                                             High colored urine 
                                                   Itching 
Fever 
Others(specify) 
PAST HISTORY 
Jaundice 
Fever/pain 
Diabetes mellitus 
Hypertension 
 PREVIOUS SURGERY 
Biliary 
Non biliary 
INVESTIGATIONS 
Hb%                                                                    PT 
TC,DC                                                                 aPTT 
RBS(FBS/PPBS)                                                Chest X ray 
Blood Urea ECG 
Serum Creatinine 
Liver Function Test 
Serum Bilirubin- Direct 
Indirect 
Alkaline phosphate 
AST 
ALT 
GGT 
Total Protein 
Serum albumin 
Serum globulin 
Serum amlyase(if necessary) 
USG: Gall Bladder Wall 
Stones 
CBD Size 
Stones 
Liver  Intra hepatic biliary dilation 
Others (specify) 
ERCP: CBD Diameter 
Stones 
BILE CULTURE: Organism cultured 
TREATMENT: 
ERCP            Pre/Post Cholecystectomy 
Indication 
Results 
Complications 
OPEN SURGERY    Per op Cholangiogram 
Indication 
Biliary Enteric drainage 
10th day T-tube cholangiogram report 
Result 
                                        10.MASTER CHART
S.No IP 
No.
NAME AG
E
SE
X
TYPE OF 
PROCEDURE
HOS
P.
STA
Y
USG CBD 
CALCULI
USG CBD 
DIAMETE
R
(IN MM)
CONJ.BILIRUBI
N
POST.OP 
COMPLICATION
S
1. 5508
0
SAKUNTHALA 28 F ERCP 8 SINGLE 10 0.6
2. 6522
8
DEIVANAI 53 F CBDE+CD 17 NIL 8 0.8 SSI
3. 6543
2
DURGAI 51 F ERCP 11 MULTIPL
E
17 3.7
4. 6623
2
ANBUJAM 62 F CBDE+T-TUBE 12 MULTIPL
E
8 1.7
5. 6016
3
ANANDAN 29 M CBDE+CD 15 MULTIPL
E
15 5.9
6. 6559
0
ARJUNAN 53 M ERCP 10 SINGLE 8 0.9 PANCREATITIS
7. 7076
6
FIAZ 45 M CBDE+T-TUBE 11 MULTIPL
E
11 2.9
8. 7016
3
SUYAMBAKANI 55 F CBDE+T-TUBE 17 NIL 9 0.9 LRTI
9. 6943
9
INDIRANI 47 F CBDE+T-TUBE 23 MULTIPL
E
19 5.8
10. 6104 SUDHA 34 F CBDE+CD 17 MULTIPL 15 5.5 BILE LEAK
1 E
11. 7210
3
SEETHARAMAN 66 M ERCP 11 SINGLE 11 2.8
12. 1098
3
SELVARANI 32 F CBDE+T-TUBE 25 NIL 12 5.6
13. 5471
1
KOKILA 63 F CBDE+T-TUBE 18 SLUDGE 11 2.3 SSI
14. 5947
1
BHAVANI 25 F ERCP 13 SINGLE 14 5.4
15. 6541
1
SANTHA 62 F CBDE+T-TUBE 26 MULTIPL
E
8 0.8
16. 7002
9
GYATHRI 47 F CBDE+T-TUBE 29 SINGLE 10 2.8
17. 6349
9
THANGARAJ 27 M ERCP 14 MULTIPL
E
16 5.3
18. 7795
9
RADHAKRISHNAN 61 M CBDE+T-TUBE 30 MULTIPL
E
12 4.9 SSI
19. 7883
7
CHELLAN 33 M CBDE+T-TUBE 12 MULTIPL
E
8 0.9
20. 7883
2
BHUVANESWARI 37 F CBDE+T-TUBE
PRE.ERCP 
INCOMPLETE
18 MULTIPL
E
11 5.1
21. 7180
4
RAJENDRAN 50 M ERCP 9 SINGLE 9 2.9
22. 8764
1
RAVI 35 M CBDE+T-TUBE 13 SINGLE 14 4.2 LRTI
23. 8347 CHITHRA 38 F CBDE+T-TUBE 14 MULTIPL 13 4.7
2 E
24. 8509
0
RAMACHANDRAN 63 M CBDE+T-TUBE 16 MULTIPL
E
10 2.9
25. 9257
2
RUCKMANI 61 F CBDE+T-TUBE
PRE.ERCP 
INCOMPLETE
19 MULTIPL
E
16 4.6 SSI
26. 8734
3
VASANTHI 41 F CBDE+T-TUBE 23 SLUDGE 11 2.8
27. 8438
1
KANNIAPPAN 55 M CBDE+CJ 20 MULTIPL
E
15 4.2
28. 5517
2
VADIVU 54 F CBDE+T-TUBE 17 MULTIPL
E
13 2.9
29. 6762
3
TAMILARASI 43 F CBDE+CD 24 MULTIPL
E
14 2.4
30. 8910
9
KANNAN 70 M ERCP 19 SINGLE 11 2.2 PANCREATITIS
31. 2134
2
MANOHARAN 54 M CBDE+CD 24 MULTIPL
E
9 0.9
32. 1865
7
ELLAMMAL 52 F CBDE+T-TUBE
PRE.ERCP 
INCOMPLETE
13 MULTIPL
E
10 2.5
33. 1765
6
VENKATAMMAL 57 F CBDE+T-TUBE 11 MULTIPL
E
12 2.8
34. 3485
9
RENUKA DEVI 47 F ERCP 08 MULTIPL
E
10 2.7
35. 4523
6
AIYSHA BEEVI 51 F CBDE+T-TUBE 15 MULTIPL
E
14 4.9
36. 6574 RAJESH 25 M CBDE+T-TUBE 19 MULTIPL 15 4.1 LRTI
3 PRE.ERCP 
INCOMPLETE
E
37. 6759
1
VENDA 42 F ERCP 15 MULTIPL
E
13 2.9
38. 7865
1
RAJA 44 M CBDE+T-TUBE 17 MULTIPL
E
11 2.7 SSI
39. 9876
2
ANBUKARASI 58 F CBDE+T-TUBE 15 SLUDGE 9 0.7
40. 8821
7
EAMBARAM 62 M ERCP 16 MULTIPL
E
10 2.2
41. 1109 AMBUJAM 72 F CBDE+T-TUBE 16 MULTIPL
E
19 12.7 LRTI
42. 8971 KANAKA 42 F CBDE+T-TUBE 17 MULTIPL
E
11 2.9
43. 1109
4
PARAMASIVAM 42 M CBDE+T-TUBE 15 MULTIPL
E
12 4.6
44. 3289
4
RAJESWARI 54 F CBDE+T-TUBE 18 MULTIPL
E
21 11.9 SSI
45. 4572
8
BASHA 48 M CBDE+T-TUBE 15 MULTIPL
E
14 4.9
46. 5436
2
BABYAMMAL 52 F CBDE+T-TUBE
PRE.ERCP 
INCOMPLETE
18 MULTIPL
E
`15 4.6
47. 7625
2
MURUGAMMAL 42 F CBDE+T-TUBE 19 MULTIPL
E
18 10.7
48. 8975
5
MALARODI 49 F CBDE+T-TUBE 16 MULTIPL
E
17 4.5
49. 9021
3
RAMASAMY 59 M CBDE+T-TUBE 25 MULTIPL
E
15 4.7
50. 785 VIMALA 68 F CBDE+T-TUBE 29 MULTIPL
E
25 15.6 SSI
 
